Roper Industries signs definitive agreements to acquire Data Innovations, SoftWriters

NewsGuard 100/100 Score

Roper Industries, Inc. (NYSE: ROP) today announced that it has entered into definitive agreements to acquire two medical software companies: Data Innovations, LLC and SoftWriters, Inc.

Data Innovations is a leading provider of middleware software for hospital and reference laboratories on a global basis. Data Innovations has the world's largest library of proprietary interfaces and drivers that support over 1,000 different lab instruments in over 80 countries serving over 4,500 customers. Data Innovations will work closely with our Sunquest business. The management team, led by Mike Epplen, will remain in place and continue to lead the business from its Burlington, VT headquarters.

SoftWriters is a leading provider of operating software and solutions for long-term care pharmacies. SoftWriters' flexible, customized software solutions are created specifically for the unique processes of long-term care, closed-door and specialty pharmacies. SoftWriters will work closely with our MHA business. The management team, led by Tim Hutchison, will remain in place and continue to lead the business from its Pittsburgh, PA headquarters.

"Both Data Innovations and SoftWriters have market-leading technology and terrific leadership teams," said Brian Jellison, Roper's Chairman, President and CEO. "We welcome these two outstanding and strategic businesses to the Roper family."

"Data Innovations and SoftWriters will be excellent building blocks in our growing medical platform," added Neil Hunn, Group Vice President for Roper's Medical businesses, "Data Innovations advances Sunquest's interoperability strategy and builds on our leadership position in the laboratory software space. SoftWriters adds to MHA's considerable presence in the long-term care pharmacy market."

Both acquisitions are expected to close in February, subject to regulatory approval and customary closing conditions. The combined purchase price for these two acquisitions is $450 million. Including the previously announced acquisition of Strata Decision Technology, Roper will have invested $590 million in these three acquisitions. The Company expects the three acquisitions to contribute approximately $100 million of annual revenue and provide over $110 million of gross cash tax benefits.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Lurie Children's Hospital administers first gene therapy for Duchenne muscular dystrophy in Illinois